Literature DB >> 30194347

Rodent models for Alzheimer disease.

Jürgen Götz1, Liviu-Gabriel Bodea2, Michel Goedert3.   

Abstract

Animal models are indispensable tools for Alzheimer disease (AD) research. Over the course of more than two decades, an increasing number of complementary rodent models has been generated. These models have facilitated testing hypotheses about the aetiology and progression of AD, dissecting the associated pathomechanisms and validating therapeutic interventions, thereby providing guidance for the design of human clinical trials. However, the lack of success in translating rodent data into therapeutic outcomes may challenge the validity of the current models. This Review critically evaluates the genetic and non-genetic strategies used in AD modelling, discussing their strengths and limitations, as well as new opportunities for the development of better models for the disease.

Entities:  

Mesh:

Year:  2018        PMID: 30194347     DOI: 10.1038/s41583-018-0054-8

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  83 in total

Review 1.  Promoter DNA hypermethylation - Implications for Alzheimer's disease.

Authors:  Yiyuan Liu; Minghui Wang; Edoardo M Marcora; Bin Zhang; Alison M Goate
Journal:  Neurosci Lett       Date:  2019-07-24       Impact factor: 3.046

2.  Aβ Plaques.

Authors:  Lary C Walker
Journal:  Free Neuropathol       Date:  2020-10-30

3.  Tau Protein and Frontotemporal Dementias.

Authors:  Michel Goedert; Maria Grazia Spillantini; Benjamin Falcon; Wenjuan Zhang; Kathy L Newell; Masato Hasegawa; Sjors H W Scheres; Bernardino Ghetti
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Pharmacological Effects of Melatonin as Neuroprotectant in Rodent Model: A Review on the Current Biological Evidence.

Authors:  Hui Ying Tan; Khuen Yen Ng; Rhun Yian Koh; Soi Moi Chye
Journal:  Cell Mol Neurobiol       Date:  2019-08-21       Impact factor: 5.046

5.  Orientin Improves Cognition by Enhancing Autophagosome Clearance in an Alzheimer's Mouse Model.

Authors:  Yi Zhong; Qing-Yu Zheng; Cheng-Yan Sun; Ze Zhang; Kun Han; Ning Jia
Journal:  J Mol Neurosci       Date:  2019-06-26       Impact factor: 3.444

6.  Role of Kalirin and mouse strain in retention of spatial memory training in an Alzheimer's disease model mouse line.

Authors:  Lillian Russo-Savage; Vishwanatha K S Rao; Betty A Eipper; Richard E Mains
Journal:  Neurobiol Aging       Date:  2020-07-14       Impact factor: 4.673

Review 7.  Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing.

Authors:  Jiansong Fang; Andrew A Pieper; Ruth Nussinov; Garam Lee; Lynn Bekris; James B Leverenz; Jeffrey Cummings; Feixiong Cheng
Journal:  Med Res Rev       Date:  2020-07-13       Impact factor: 12.944

Review 8.  Immune Signaling in Neurodegeneration.

Authors:  Timothy R Hammond; Samuel E Marsh; Beth Stevens
Journal:  Immunity       Date:  2019-04-16       Impact factor: 31.745

9.  Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease.

Authors:  Ethan R Roy; Baiping Wang; Ying-Wooi Wan; Gabriel Chiu; Allysa Cole; Zhuoran Yin; Nicholas E Propson; Yin Xu; Joanna L Jankowsky; Zhandong Liu; Virginia M-Y Lee; John Q Trojanowski; Stephen D Ginsberg; Oleg Butovsky; Hui Zheng; Wei Cao
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

Review 10.  Cerebrovascular phenotypes in mouse models of Alzheimer's disease.

Authors:  Jenny I Szu; André Obenaus
Journal:  J Cereb Blood Flow Metab       Date:  2021-02-08       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.